The Patent Finder

Oncimmune Ltd.

Also on record
Records under this name other than the patents Oncimmune Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 9 of 9 · Back to Oncimmune Ltd.

PatentTitleStatus Expires Confidence
US 9,714,938Immunoassay methods
Term ended
Ended no later than May 26, 2026 · From the USPTO record
Term endedEnded no later than May 26, 2026From the USPTO record
US 9,719,984Immunoassay methods
Term ended
Ended no later than May 26, 2026 · From the USPTO record
Term endedEnded no later than May 26, 2026From the USPTO record
US 8,592,169Tumour marker proteins and uses thereof
Term ended
Term ended Nov 13, 2023 · From the USPTO record
Term endedTerm ended Nov 13, 2023From the USPTO record
US 8,574,848Immunoassay methods
Lapsed on the fee record
Ended Nov 5, 2021 · From the USPTO record
Lapsed on the fee recordEnded Nov 5, 2021From the USPTO record
US 9,696,319Tumour markers
Term ended
Term ended Feb 2, 2021 · From the USPTO record
Term endedTerm ended Feb 2, 2021From the USPTO record
US 8,114,604Tumour markers
Term ended
Term ended Nov 27, 2019 · From the USPTO record
Term endedTerm ended Nov 27, 2019From the USPTO record
US 7,402,403Tumour markers
Term ended
Term ended May 11, 2019 · From the USPTO record
Term endedTerm ended May 11, 2019From the USPTO record
US 7,205,117Cancer detection method and reagents
Lapsed on the fee record
Ended Apr 17, 2019 · From the USPTO record
Lapsed on the fee recordEnded Apr 17, 2019From the USPTO record
US 8,927,223Immunoassay methods
Lapsed on the fee record
Ended Jan 6, 2019 · From the USPTO record
Lapsed on the fee recordEnded Jan 6, 2019From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited